The organization’s board of directors declined to discuss details of the termination, citing employee confidentiality, the Gazette reported.
Dr. Gibb became CEO in July 2017, prior to being interim CEO and CMO. He joined Billings Clinic, a physician-led multispecialty group practice with a 304-bed hospital and a level 2 trauma center, in 2006, providing care as a gynecologic oncologist.
Billings Clinic named Robert Merchant, MD, and John Schallenkamp, MD, interim co-CEOs. Dr. Merchant is CMO of the organization and a practicing pulmonary, critical care and sleep medicine physician, while Dr. Schallenkamp is medical director of the Billings Clinic Cancer Center and a practicing radiation oncologist. Dr. Schallenkamp is also a member of Billings’ board.
Dr. Schallenkamp told the Gazette that the organization decided to appoint co-CEOs because both he and Dr. Merchant are still practicing.
“I would say it would be kind of difficult to drop our patients and practices,” he said, according to the report. “So together, we’re going to be able to fulfill all our requirements.”
The organization plans to select a single CEO as a permanent replacement for Dr. Gibb, Dr. Schallenkamp told the Gazette.
More articles on executive moves:
MD Anderson names Dr. David Jaffray 1st chief technology and digital officer
Massachusetts General Hospital appoints its first chief equity and inclusion officer
21 recent hospital, health system CNO and CMO moves
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
